Author:
Stanislaus Peter,Zaak Dirk,Stadler Thomas,Tritschler Stefan,Knüchel Ruth,Stief Christian G.,Karl Alexander
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Soloway MS, Sofer M, Vaidya A (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573–1583
2. Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T (2007) Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8 year results of prospective randomized study. Urology 69:675–679
3. Herr HW (1997) Tumour progression, survival in patients with T1G3 bladder tumours, 15 year outcome. Br J Urol 80:762–765
4. Bono AV, Lovisolo JA, Saredi G (2003) Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer. Eur Urol 37:478–483
5. Catanzaro F, Torelli F, Catanzaro M, Cappellano F, Pizzoccaro M, Baruffi M, Sironi D, Pozzoli GL (1996) Conservative treatment of high-risk (T1G3) transitional carcinoma. Arch Ital Urol Androl 68:21–24
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献